Cargando…
Optimal Strategy for Colorectal Cancer Patients' Diagnosis Based on Circulating Tumor Cells and Circulating Tumor Endothelial Cells by Subtraction Enrichment and Immunostaining-Fluorescence In Situ Hybridization Combining with CEA and CA19-9
BACKGROUND: Cancerous embryo antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) are commonly used in clinical practice to assist in diagnosing CRC. However, their sensitivity is very low. This study aims to investigate the clinical significance of circulating tumor cells (CTCs) and circulating tum...
Autores principales: | Luo, Shimu, Ou, Yanghang, Zheng, Tingjin, Jiang, Huihui, Wu, Yibo, Zhao, Jiangman, Zhang, Zhishan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720022/ https://www.ncbi.nlm.nih.gov/pubmed/34976053 http://dx.doi.org/10.1155/2021/1517488 |
Ejemplares similares
-
Clinical significance of detecting circulating tumor cells in colorectal cancer using subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH)
por: Wu, Wei, et al.
Publicado: (2017) -
Clinical significance of detecting circulating tumor cells in patients with esophageal squamous cell carcinoma by EpCAM-independent enrichment and immunostaining-fluorescence in situ hybridization
por: Zhang, Yaowen, et al.
Publicado: (2019) -
Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization
por: Gao, Yang, et al.
Publicado: (2016) -
Circulating tumor cells detection in neuroblastoma patients by EpCAM-independent enrichment and immunostaining-fluorescence in situ hybridization
por: Liu, Xiangqi, et al.
Publicado: (2018) -
Strategies for enrichment of circulating tumor cells
por: Li, Xinchun, et al.
Publicado: (2020)